Gain Therapeutics, Inc.

UBS Group AG GANX

Report date

9/30/2026

Quarter

2026 Q3

Filed

11/10/2026

Shares

241,483

Value ($000)

418

Weight

0.0%

2021 Q1 - 2026 Q3 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q3	11/10/2026	418	0.0%	241,483	9/30/2026
2026 Q2	8/13/2026	436	0.0%	215,012	6/30/2026
2026 Q1	5/5/2026	428	0.0%	220,489	3/31/2026
2025 Q4	1/29/2026	261	0.0%	81,121	12/31/2025
2025 Q3	11/13/2025	249	0.0%	140,677	9/30/2025
2025 Q2	8/14/2025	59	0.0%	32,635	6/30/2025
2025 Q1	5/13/2025	83	0.0%	43,360	3/31/2025
2024 Q4	2/14/2025	76	0.0%	35,227	12/31/2024
2024 Q3	11/14/2024	15	0.0%	8,455	9/30/2024
2024 Q2	8/14/2024	15	0.0%	11,422	6/30/2024
2024 Q1	5/13/2024	33	0.0%	8,673	3/31/2024
2023 Q4	2/9/2024	46	0.0%	14,023	12/31/2023
2023 Q3	11/9/2023	27	0.0%	8,304	9/30/2023
2023 Q2	8/11/2023	42	0.0%	9,447	6/30/2023
2023 Q1	5/12/2023	21	0.0%	4,305	3/31/2023
2022 Q4	2/8/2023	23	0.0%	7,289	12/31/2022
2022 Q3	11/10/2022	13	0.0%	4,122	9/30/2022
2022 Q2	8/10/2022	23	0.0%	6,411	6/30/2022
2022 Q1	5/16/2022	17	0.0%	4,100	3/31/2022
2021 Q4	2/14/2022	57	0.0%	10,497	12/31/2021
2021 Q3	11/15/2021	51	0.0%	6,740	9/30/2021
2021 Q2	8/13/2021	41	0.0%	4,100	6/30/2021
2021 Q1	5/12/2021	91	0.0%	6,105	3/31/2021